Home/Insights/How Much Data a Clinic Needs to Review Vendor Costs
Vendor Cost ManagementCura Insight
How Much Data Does a Veterinary Clinic Need to Review Vendor Costs?
A useful vendor-cost review can often begin with information a veterinary practice already has, then become more detailed only where the potential decision warrants it.
Brian Fosselman, Founder, Cura Veterinary PartnersAugust 20, 2026Approximately 10-minute read
A veterinary practice can recognize that its vendor costs deserve a closer look and still struggle to get a review started. The obstacle is not always lack of interest. Sometimes it is the assumption that meaningful analysis cannot begin until the clinic has assembled every contract, purchasing report, invoice, rate sheet, rebate schedule, credit-card statement, and usage record associated with its vendors.
For a busy independent practice, that can turn a reasonable business exercise into a substantial administrative project before any analysis has taken place. Agreements may sit in different folders or inboxes. Some purchasing information may be available through distributors or manufacturers rather than the clinic's own systems. A practice may know what it spends with a vendor without having an immediately accessible breakdown of every product or service behind that amount.
Complete information eventually matters for some decisions, but it does not necessarily need to come first. The initial stage of a vendor-cost review does not need to answer every commercial question. It needs to provide enough visibility to determine which questions are worth answering next. Accounting records, credit-card activity, vendor lists, recent invoices, and whatever agreements are readily available can often establish a useful starting point.
More detailed information can then be gathered selectively for the vendor relationships where spend, timing, pricing, contractual terms, or operational considerations justify a closer look. Approaching the review in stages can materially reduce the amount of work required before useful analysis begins.
What clinic owners should know
A useful first pass does not require perfect records. Existing financial and purchasing information can often establish where money is going and which vendor relationships deserve greater attention.
Different data answers different questions. A general ledger can help identify spend concentration, but it cannot determine whether a contract's renewal provisions are favorable. An invoice can show current pricing, but it may not explain rebate eligibility or volume commitments.
Prioritization should come before exhaustive data collection. Gathering detailed records for every vendor can consume substantial time without improving many decisions. Broad information can first narrow the field.
Spend matters, but it is not the only reason to investigate a vendor. Renewal timing, pricing concerns, contractual exposure, operational importance, service issues, and the difficulty of changing an arrangement can all affect priority.
The depth of analysis should rise with the consequence of the decision. A major clinical purchasing relationship or long-term agreement generally deserves more diligence than a small, stable service category with limited financial or operational significance.
Incomplete information does not always stop the review. In some cases, discovering that a material agreement, pricing structure, or renewal provision is difficult to identify is itself a reason to clarify the relationship.
Industry Context
Several established veterinary-management resources reinforce an important distinction between the information needed to identify an area for investigation and the more detailed information needed to make a specific decision.
Financial analysis often becomes more detailed in stages.
AAHA guidance on veterinary practice financial analysis recommends beginning with a defined question and baseline information, then investigating areas where the initial analysis suggests further attention may be useful. As the analysis becomes more detailed, additional data sources may be needed.
Veterinary accounting information is designed to support management decisions.
The VMG/AAHA Chart of Accounts, updated in 2026 and reviewed by organizations including AVMA, VHMA, and VetPartners, provides a standardized framework for classifying practice revenue and expenses in a way intended to improve financial reporting, benchmarking, and business analysis.
Detailed vendor decisions require more than spend totals.
VetPartners' vendor-management guidance identifies factors such as pricing structure, contract term, renewal provisions, volume commitments, performance expectations, cancellation rights, and expected usage as relevant when a practice evaluates a specific vendor agreement.
These sources do not establish a universal data requirement for a veterinary vendor-cost review, nor would a single requirement be particularly useful across every clinic and category. They do, however, provide relevant industry context for a practical analytical principle: broad information can help identify where investigation is warranted, while deeper information becomes more useful as the business question becomes more specific.
Start with visibility, not completeness
A vendor-cost review usually involves different levels of analysis that are easy to conflate. Early screening is intended to understand where the clinic spends money, identify material vendor relationships, recognize upcoming decisions, and determine which categories appear worthy of further investigation. Decision analysis goes further by evaluating whether a particular relationship should remain unchanged, be renegotiated, be structured differently, or be compared with alternatives.
Those stages do not require the same information. At the screening stage, the practice is trying to create enough visibility to allocate attention intelligently. A general ledger or accounts-payable report can help identify major vendors and expense categories. Credit-card transactions can capture recurring expenses that may not be obvious from a vendor list, while recent invoices can provide an initial view of pricing, fees, quantities, and service structure. Available contracts may also flag renewal dates or commitments without requiring the clinic to locate every historical document before proceeding.
The relevant threshold at this stage is not whether the practice possesses every piece of information that could eventually matter. It is whether the available information is sufficient to identify where a closer look is justified. Framing the question that way creates a much more manageable starting point.
Existing accounting information can reveal more than it may appear
A clinic's accounting records will rarely provide everything needed for a vendor decision, but they can answer several important first questions. They can help establish which vendor relationships account for meaningful annual spend, whether certain expense categories are fragmented across several suppliers, and where recurring costs may warrant further investigation.
They can also expose issues that would be easy to miss when looking at vendors individually. Recurring payments may be appearing on credit cards rather than through accounts payable, multiple suppliers may contribute to what appears to be a single expense category, or a vendor relationship may be large enough that even a modest commercial improvement could justify additional analysis.
Ordinary practice financial data can therefore serve as a useful screening tool even when it is not sufficiently detailed to support a final recommendation. Its limitations should also be understood from the outset.
A line labeled "laboratory expense" may reveal the magnitude of spending without showing test mix, individual test pricing, equipment obligations, or contractual concessions. A pharmaceutical or medical-supplies account may aggregate purchases from manufacturers and distributors that operate under different rebate programs. A software expense may reveal what the clinic paid last year without explaining which features the team actually uses or when the agreement can be terminated. Broad financial data can help determine where to look, while the appropriate course of action usually requires additional information.
Exhibit 1
A vendor-cost review should become more detailed as it narrows
Detailed information should generally follow prioritization rather than automatically precede it.
1START BROADLY
Build visibility using information that is already accessible
Accounting records
Accounts-payable activity
Credit-card transactions
Vendor list
Recent invoices
Available agreements
2PRIORITIZE
Determine where additional analysis is worth the effort
Spend magnitude
Renewal timing
Pricing questions
Contract timing and exposure
Operational importance
Potential decision consequence
3DEEPEN SELECTIVELY
Gather the detail required to evaluate specific relationships
Contract terms and amendments
Item-level purchasing or usage data
Rate and fee schedules
Rebate and incentive terms
Service requirements
Competitive market information
Increasing analytical depth
Source: Cura Veterinary Partners analysis.
Not every vendor deserves the same level of analysis
Treating every supplier as though it deserves identical diligence can make a vendor review unnecessarily burdensome. The economic and operational importance of vendor relationships varies considerably, so the effort devoted to understanding them should vary as well.
Consider two vendor relationships. One represents a modest annual expense, has no known service or pricing concerns, operates without a restrictive long-term commitment, and would create little economic impact even if pricing improved. The other represents a meaningful portion of annual operating expense, has a renewal approaching, includes multiple pricing components, and is operationally important to the hospital. Requiring the same information package for both would create activity without necessarily creating value.
Spend is an obvious prioritization factor, but it should not operate alone. A lower-spend vendor with an imminent automatic renewal may deserve attention before a larger relationship whose terms were recently reviewed. A clinically important supplier with limited substitutes may warrant careful contract and supply-risk analysis even if a transition is unlikely. A service that has generated repeated pricing questions may justify investigation despite representing less spend than other categories.
This general principle is also consistent with established procurement practice. The Chartered Institute of Procurement & Supply describes supplier and category prioritization using factors such as economic importance, business impact, and supply risk so that attention can be directed where it is most valuable. An independent veterinary clinic does not need to turn this into a formal procurement exercise; the practical issue is whether obtaining more information about a particular relationship is likely to improve an actual decision.
Deeper data becomes valuable when the question becomes specific
Once a vendor or category has been prioritized, broad financial information becomes less sufficient. The questions are no longer limited to how much the practice spends or when the relationship renews. The clinic may now need to understand why the current cost exists, what contractual rights and obligations apply, whether viable alternatives exist, and how a potential change would affect operations.
Suppose a clinic determines that a major software agreement warrants review because spending has increased and renewal is approaching. At that point, annual spend alone tells very little about the right course of action. The analysis may require the executed contract, renewal language, user counts, module utilization, implementation dependencies, service requirements, historical pricing, and available alternatives.
A clinical purchasing category could require an entirely different dataset. Understanding pharmaceutical or medical-supply economics may involve item-level purchasing records, manufacturer programs, distributor pricing, rebates, volume thresholds, product substitutions, inventory requirements, and the clinical preferences of the practice. A laboratory arrangement may instead require test utilization, pricing by test or profile, equipment obligations, service requirements, pickup logistics, turnaround expectations, and contract provisions.
As the business question becomes more specific, the information required to answer it becomes more detailed. Agreements, purchasing histories, usage reports, pricing schedules, and market proposals can be highly valuable when there is already a reason to believe that a relationship deserves the additional work. Collecting that level of detail indiscriminately across every vendor would reverse the analytical sequence and create substantial work before its usefulness is known.
Exhibit 2
Different questions require different levels of information
The appropriate data request depends on the business question being answered.
Business question
Information that can often support the initial view
Additional detail when the relationship warrants deeper review
Contract rights, service requirements, implementation implications, operational tradeoffs
Source: Cura Veterinary Partners analysis.
Missing information can be a finding, not just an obstacle
An incomplete record set can sometimes reveal something useful about the way a vendor relationship is being managed. The absence of information does not prove that a commercial problem exists, but it can identify an area where greater visibility would improve future decision-making.
If a practice cannot readily determine when an important agreement renews, for example, there is no basis to conclude that the agreement is unfavorable. There is, however, a reason to improve renewal visibility. Likewise, if the pricing schedule governing a major service cannot be identified, the immediate conclusion should not be that the vendor is overcharging; the clinic first needs to establish the current commercial baseline before evaluating it.
Purchasing activity can create a similar challenge when it is distributed across manufacturer accounts, distributors, credit cards, and rebate programs. The fragmentation may help explain why an apparently straightforward expense category is difficult to evaluate, and the first useful outcome of the review may simply be reconstructing how the economics fit together.
None of these situations should be interpreted as evidence of poor management. Veterinary practices are clinical organizations first. Vendor information accumulates over years, staff roles change, programs evolve, suppliers change representatives, and purchasing responsibilities may be distributed across owners, managers, technicians, bookkeepers, and outside advisors. A structured review is intended to make that information decision-ready where doing so matters, not to criticize the way it was stored beforehand.
An illustrative practice does not need to investigate everything at once
Consider an illustrative independent veterinary clinic reviewing its recurring vendor relationships. The initial financial picture identifies a mix of pharmaceutical and medical-supply vendors, reference laboratory services, prescription diets, software platforms, payment processing, phones, waste services, insurance, equipment-related services, and a number of smaller recurring suppliers.
Some relationships may require little immediate attention. A small service agreement might have renewed recently, operate reliably, and represent limited annual spend. Unless another concern emerges, extensive data collection may not be worth the team's time. A second relationship could represent substantial spending but appear operationally strong, making the more appropriate next step a review of purchasing detail, current program terms, and applicable rebates rather than an assumption that the vendor should be replaced.
A third vendor may have an agreement approaching renewal, causing contract terms and notice requirements to deserve attention even though the category is not among the clinic's largest expenses. A fourth category may look promising based on annual spend and current pricing, leading the clinic to obtain more detailed utilization information and evaluate the incumbent alongside credible market alternatives.
Those four relationships could reasonably produce four different decisions: defer one category, retain and clarify another, renegotiate a third, and market-test the fourth. A review that reaches those conclusions has accomplished something useful without first building a perfect dataset for every vendor in the practice.
The clinic's time should be treated as part of the economics
Information gathering is not free simply because it does not appear on an invoice. A practice manager who spends hours locating agreements, reconciling statements, exporting purchasing histories, requesting reports, and answering vendor questions is using time that would otherwise be spent managing the hospital. Veterinarians and clinical team members may also need to weigh in when service quality, product preferences, workflow, or patient-care considerations affect the analysis.
Detailed data collection can be entirely justified when the potential decision warrants it. For a material vendor relationship, the work required to reconstruct the commercial picture may be modest relative to the financial or operational implications. For a small category with limited decision consequence, the same exercise may consume more internal effort than the resulting information is likely to justify.
A disciplined review therefore considers both the information that could theoretically be analyzed and the value of obtaining it at a particular point in the process. That keeps analytical rigor from becoming unnecessary administrative burden.
Where Cura fits
Cura Veterinary Partners does not require a clinic to assemble a perfect vendor data room before useful work can begin. A review can often start with information that is already readily available, including accounting records, vendor spend, credit-card activity, invoices, known vendor relationships, and agreements the practice can easily locate. That initial information helps establish the spend baseline and identify the categories where additional work is likely to be worthwhile.
The information request can then become more targeted as specific opportunities are investigated. Where additional detail is necessary, Cura works with the clinic to determine exactly what is needed for the vendor or category being evaluated. With the clinic's authorization, Cura can also coordinate directly with incumbent vendors, distributors, brokers, and other relevant parties to obtain appropriate pricing records, agreements, purchasing reports, program information, rate schedules, or other commercial details.
This approach does not eliminate the clinic's involvement, nor should it. The practice remains essential when clinical preferences, service experience, workflow requirements, relationship considerations, or implementation constraints need to be understood because those factors cannot be reconstructed from an invoice or spreadsheet. The objective is to limit the clinic's involvement in administrative work that can reasonably be handled elsewhere while preserving its involvement in the decisions where its judgment is indispensable.
Cura can therefore help identify which information is worth pursuing, coordinate much of the commercial fact-gathering, evaluate the available options, and bring the practice team back into the process where its input is most valuable. The review is built around the significance of each opportunity rather than the completeness of the files available on the first day.
Cura's perspective
Good analysis requires good information, but it does not require every possible piece of information at the same time. For most veterinary practices, a more practical sequence is to establish visibility first and determine which relationships merit further attention before investing in deeper data collection.
Some categories will ultimately require substantial detail, including contracts, purchasing histories, utilization records, pricing schedules, or competitive market information. Others may require relatively little additional work, and a few may be deprioritized once the initial facts are understood. Applying the same data requirement to every vendor would add work without necessarily improving the quality of the decisions.
A strong vendor-cost review is therefore not defined by how much data it collects. It is defined by whether the right information is available when that information can meaningfully improve a commercial or operational decision.
Could incomplete data be delaying a vendor review at your clinic?
A practical first step may require less information than expected. Cura Veterinary Partners can begin with the records already available, help identify where deeper analysis is worthwhile, and support the additional fact-gathering needed to evaluate prioritized vendor relationships.
Brian Fosselman is the founder of Cura Veterinary Partners. His background includes management consulting work focused on procurement-related cost optimization, strategic negotiations, and business performance improvement. Through Cura, he helps independent veterinary clinics evaluate vendor spend, negotiate stronger agreements, and improve cash flow while limiting additional demands on clinical teams.